Yield10 Bioscience Inc expected to post a loss of 60 cents a share - Earnings Preview

Yield10 Bioscience

03/03/2023 22:31

* Yield10 Bioscience Inc  YTEN.OQ   YTEN.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 7
(estimated). 
    * The Woburn Massachusetts-based  company is expected to
report  a
17.8% decrease in revenue to $125 thousand from $152 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Yield10 Bioscience
Inc is
for a loss of 60 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Yield10
Bioscience Inc is $12​, above​ its last closing price of $2.90.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.65       -0.65      -0.71     Missed  -9.2
 Jun. 30 2022  -0.69       -0.69      -0.70     Missed  -1.4
 Mar. 31 2022  -0.65       -0.65      -0.68     Missed  -4.2​
 Dec. 31 2021  -0.64       -0.63      -0.61     Beat    3.9
 ​​Sep.        -0.65       -0.65      -0.49     Beat    24.6
 30 2021                                                
 Jun. 30 2021  -0.54       -0.54      -0.64     Missed  -18.5​
 Mar. 31 2021  -0.54       -0.55      -0.60     Missed  -8.1
 Dec. 31 2020              -0.70      -0.79     Missed  -13.3
 This summary was machine generated March 3 at 22:31 GMT.  All
figures in US dollars  unless otherwise stated